MRNA vs NOMA · rev $145.0M vs rev $6.4K
Moderna Inc (MRNA) versus NOMADAR Corp. Class A Common Stock (NOMA) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
NOMADAR Corp. Class A Common Stock (NOMA) is a leisure company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported NOMA revenue for 2025-12-31 was $6.4K. Net income was -$2.8M. Revenue was down 20.5% from 2024-12-31 to 2025-12-31. NOMA currently screens at market cap $58.4M.
MRNA currently screens at market cap $24.52B. NOMA currently screens at market cap $58.4M.
Not investment advice. Open the MRNA and NOMA stock pages for the full models.
Not investment advice.